Inventor
KADDURAH-DAOUK RIMA
US27 patents
⚠️ This page may combine multiple inventors who share the name “KADDURAH-DAOUK RIMA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
METABOLON INC
6 patentsUS7329489B2Feb 12, 2008
Methods for drug discovery, disease treatment, and diagnosis using metabolomics
METABOLON INC86 citations98
US7550260B2Jun 23, 2009
Methods for drug discovery, disease treatment, and diagnosis using metabolomics
METABOLON INC27 citations95
US7550258B2Jun 23, 2009
Methods for drug discovery, disease treatment, and diagnosis using metabolomics
METABOLON INC30 citations95
US7553616B2Jun 30, 2009
Methods for drug discovery, disease treatment, and diagnosis using metabolomics
METABOLON INC23 citations92
US7947453B2May 24, 2011
Methods for drug discovery, disease treatment, and diagnosis using metabolomics
METABOLON INC6 citations73
US7910301B2Mar 22, 2011
Methods for drug discovery, disease treatment, and diagnosis using metabolomics
METABOLON INC6 citations73
CORNELL RES FOUNDATION INC
4 patentsUS7005255B2Feb 28, 2006
Methods for drug discovery, disease treatment, and diagnosis using metabolomics
CORNELL RES FOUNDATION INC118 citations98
US7682783B2Mar 23, 2010
Methods for drug discovery, disease treatment, and diagnosis using metabolomics
CORNELL RES FOUNDATION INC15 citations92
US7682784B2Mar 23, 2010
Methods for drug discovery disease treatment, and diagnosis using metabolomics
CORNELL RES FOUNDATION INC13 citations92
US7635556B2Dec 22, 2009
Methods for drug discovery, disease treatment, and diagnosis using metabolomics
CORNELL RES FOUNDATION INC26 citations92
(unassigned)
3 patentsUS6242491B1Jun 5, 2001
Use of creatine or creatine compounds for skin preservation
87 citations98
US6288124B1Sep 11, 2001
Methods of inhibiting undesirable cell growth using an aminoguanidine compound
19 citations92
US6169115B1Jan 2, 2001
Use of aminoguanidine analogs for the treatment of diseases of the nervous system
17 citations84
AMIRA INC
3 patentsUS5324731AJun 28, 1994
Method of inhibiting transformation of cells in which purine metabolic enzyme activity is elevated
AMIRA INC77 citations94
US5321030AJun 14, 1994
Creatine analogs having antiviral activity
AMIRA INC64 citations93
US5676978AOct 14, 1997
Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent
AMIRA INC48 citations91
AVICENA GROUP INC
3 patentsUS7186754B2Mar 6, 2007
Use of creatine or creatine compounds for skin preservation
AVICENA GROUP INC19 citations92
US6706764B2Mar 16, 2004
Use of creatine or creatine analogs for the treatment of diseases of the nervous system
AVICENA GROUP INC45 citations92
US5998457ADec 7, 1999
Creatine analogues for treatment of obesity
AVICENA GROUP INC47 citations92